214 related articles for article (PubMed ID: 32788493)
1. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
[TBL] [Abstract][Full Text] [Related]
2. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
[TBL] [Abstract][Full Text] [Related]
4. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
Chen Y; Zhang L; Liu WX; Liu XY
Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
[TBL] [Abstract][Full Text] [Related]
7. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
8. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.
Okunade KS; Adejimi AA; Ohazurike EO; Salako O; Osunwusi B; Adenekan MA; Ugwu AO; Soibi-Harry A; Dawodu O; Okunowo AA; Anorlu RI; Berek JS
JCO Glob Oncol; 2021 Jan; 7():89-98. PubMed ID: 33449803
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
[TBL] [Abstract][Full Text] [Related]
12. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer.
Lin YH; Wu CH; Fu HC; Chen YJ; Chen YY; Ou YC; Lin H
Cancer Biomark; 2020; 28(3):285-292. PubMed ID: 32390605
[TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
[TBL] [Abstract][Full Text] [Related]
15. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
17. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
Lee M; Kim SW; Nam EJ; Yim GW; Kim S; Kim YT
Gynecol Oncol; 2011 Aug; 122(2):238-41. PubMed ID: 21531448
[TBL] [Abstract][Full Text] [Related]
18. Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma.
Cho HW; Ouh YT; Hong JH; Lee JK
Arch Gynecol Obstet; 2021 Mar; 303(3):803-810. PubMed ID: 33078229
[TBL] [Abstract][Full Text] [Related]
19. Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria.
Okunade KS; Adetuyi IE; Adenekan M; Ohazurike E; Anorlu RI
Pan Afr Med J; 2020; 36():272. PubMed ID: 33088401
[TBL] [Abstract][Full Text] [Related]
20. Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer.
Hu Q; Hada A; Han L
J Ovarian Res; 2020 Jul; 13(1):78. PubMed ID: 32682445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
